---
$id: https://graph.org.ai/products/commodity/51162704
$type: Product
source: UNSPSC
code: "51162704"
title: "Bromhexine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromhexine

**UNSPSC Code**: 51162704
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an expectorant with the molecular formula C14H20Br2N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Q1J152VB1P, chemically known as 3,5-dibromo-nalpha-cyclohexyl-nalpha-methyltoluene-alpha-2-diamine but more generally known as bromhexine, which bears US NIH Compound Identifier 2442. Bromhexine most often comes in base, chloride, and hydrochloride forms. European Medicines Agency schedules Bromhexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05914MIG. World Health Organization schedules bromhexine in its Anatomical Therapeutic Chemical (ATC) Classification. BROMHEXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bromhexine under HS 29215990 and SITC 51455. As of Q4 2014, BROMHEXINE remains US FDA's Preferred Term for this commodity. SMILES: BRC1C(N)C(CN(C2CCCCC2)C)CC(BR)C1.

